These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38460837)

  • 1. How we forecast tomorrow's haemovigilance.
    Wood EM; Whitaker BI; Townsend M; Narayan S
    Transfus Clin Biol; 2024 May; 31(2):114-118. PubMed ID: 38460837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemovigilance: an effective tool for improving transfusion practice.
    de Vries RR; Faber JC; Strengers PF;
    Vox Sang; 2011 Jan; 100(1):60-7. PubMed ID: 21175656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haemovigilance resources available for everyone: A report from the International Haemovigilance Tools Collaborative Project.
    Townsend M; Maryuningsih Soedarmono YS; Narayan S; Ashford P; Wood EM; Whitaker BI
    Vox Sang; 2024 Mar; 119(3):277-281. PubMed ID: 38126141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. International haemovigilance: what have we learned and what do we need to do next?
    Wood EM; Ang AL; Bisht A; Bolton-Maggs PH; Bokhorst AG; Flesland O; Land K; Wiersum-Osselton JC; Schipperus MR; Tiberghien P; Whitaker BI
    Transfus Med; 2019 Aug; 29(4):221-230. PubMed ID: 30729612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Seventeen years of haemovigilance in France: assessment and outlook].
    Carlier M; Vo Mai MP; Fauveau L; Ounnoughene N; Sandid I; Renaudier P
    Transfus Clin Biol; 2011 Apr; 18(2):140-50. PubMed ID: 21474356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Approaches to advancing blood safety through haemovigilance: a review.
    Mwangi JW; Kimani D; Oduor M
    East Afr Med J; 2009 Dec; 86(12 Suppl):S93-7. PubMed ID: 21591517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight years with haemovigilance in Norway. What have we learnt?
    Steinsvåg CT; Espinosa A; Flesland Ø
    Transfus Apher Sci; 2013 Dec; 49(3):548-52. PubMed ID: 24157220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The International Haemovigilance Network Database for the Surveillance of Adverse Reactions and Events in Donors and Recipients of Blood Components: technical issues and results.
    Politis C; Wiersum JC; Richardson C; Robillard P; Jorgensen J; Renaudier P; Faber JC; Wood EM
    Vox Sang; 2016 Nov; 111(4):409-417. PubMed ID: 27658188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The new donor vigilance system in Denmark reveals regional differences in adverse reactions supposedly caused by variation in the registration.
    Mikkelsen C; Paarup HM; Bruun MT; Pedersen LØ; Hasslund S; Larsen R; Aagaard B; Sørensen BS
    Vox Sang; 2022 Mar; 117(3):321-327. PubMed ID: 34523137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [French haemovigilance from 1994 to nowadays: Evolution and prospects].
    Lassale B; Daurat G; Besse-Moreau M; Aullen JP
    Transfus Clin Biol; 2017 Sep; 24(3):268-272. PubMed ID: 28647104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The French haemovigilance system.
    Debeir J; Noel L; Aullen J; Frette C; Sari F; Mai MP; Cosson A
    Vox Sang; 1999; 77(2):77-81. PubMed ID: 10516551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality validation of data in national haemovigilance systems in Europe: report of a survey on current state of practice.
    Wiersum-Osselton JC; Faber JC; Politis C; Brand A; van der Bom JG; Schipperus MR
    Vox Sang; 2013 Apr; 104(3):214-7. PubMed ID: 23061879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The revision of the European blood directives: A major challenge for transfusion medicine.
    Folléa G; Aranko K;
    Transfus Clin Biol; 2015 Aug; 22(3):141-7. PubMed ID: 26056039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide overview of existing haemovigilance systems.
    Faber JC
    Transfus Apher Sci; 2004 Oct; 31(2):99-110. PubMed ID: 15501414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How do we forecast tomorrow's transfusion? Applying social science approaches to meet tomorrow's transfusion needs: Blood donors and donation.
    Haw J; Holloway K; Goldman M
    Transfus Clin Biol; 2023 Feb; 30(1):47-51. PubMed ID: 36372196
    [No Abstract]   [Full Text] [Related]  

  • 16. A national surveillance system for continuous monitoring of blood transfusion safety: German haemovigilance data.
    Berg P; Heiden M; Müller S; Meyer B; Witzenhausen C; Ruppert-Seipp G; Kehr S; Funk MB
    Vox Sang; 2024 Sep; 119(9):953-962. PubMed ID: 38889998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of standard definitions for surveillance of complications related to blood donation.
    Goldman M; Land K; Robillard P; Wiersum-Osselton J
    Vox Sang; 2016 Feb; 110(2):185-8. PubMed ID: 26361365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemovigilance: a joint responsibility of hospitals and blood banks].
    van Aken WG
    Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1490-2. PubMed ID: 12924077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First donor haemovigilance system at a national level in China: Establishment and improvement.
    Yang J; Fan D; Xie D; Guo X; Zhu W; He T; Huang X
    Vox Sang; 2023 May; 118(5):357-366. PubMed ID: 36896482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ensuring Safe Transfusion Practices through Haemovigilance: India
    Rana R; Veluri Kishore SR; Kaur G; Singh G; Kumar R
    Curr Drug Saf; 2023; 18(4):474-483. PubMed ID: 36475347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.